News & Media

Press release
Medivir to present at the Erik Penser Bank Health Care Day

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that its new CEO Jens Lindberg will participate at the Erik...

Read more
Press release
MEDIVIR AB – YEAR-END REPORT JANUARY – DECEMBER 2021

October – December Financial summary for the quarter Net turnover amounted to SEK 13.9 (1.5) million. The loss before interest, tax,...

Read more
Press release
Biomarker data from the fostroxacitabine bralpamide phase 1 study to be presented at the EASL Liver Cancer Summit

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that an e-poster entitled “Liver biopsy biomarkers in a phase 1...

Read more
Press release
Medivir’s MIV-818 obtains the International Nonproprietary Name fostroxacitabine bralpamide

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the World Health Organization (WHO) has selected the International Nonproprietary...

Read more
Press release
Jens Lindberg takes office as CEO of Medivir on January 24

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that Jens Lindberg will assume his position as CEO on January...

Read more
Press release
Medivir to present at the H.C. Wainwright BioConnect Virtual Conference

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the virtual meeting H.C. Wainwright...

Read more